Blog
RSS FeedPosted by Michael Wonder on 01 Mar 2017
WHO stresses urgent need for R&D for drug-resistant TB alongside newly-prioritized antibiotic-resistant pathogens
28 February 2017 - WHO reaffirms the critical need for research and development of new antibiotics to tackle the threat ...
Posted by Michael Wonder on 28 Feb 2017
Sinodinos announces intention for women's advisory roundtable
28 February 2017 - The newly-appointed Minister for Industry, Innovation and Science, Senator Arthur Sinodinos, has announced an intention to ...
Posted by Michael Wonder on 28 Feb 2017
Clinical evidence guidelines documents for medical devices
28 February 2017 - This document is intended to provide guidance to manufacturers of medical devices (including in vitro diagnostic ...
Posted by Michael Wonder on 27 Feb 2017
GSK ‘real world’ study offers new model for drug trials
27 February 2017 - Pharma groups look to evidence in normal medical settings to prove value for money. ...
Posted by Michael Wonder on 23 Feb 2017
Uncertainty on R&D tax incentive causing real harm
23 February 2017 - Constant reviews and recent changes to the Research and Development (R&D) Tax Incentive are jeopardising Australian ...
Posted by Michael Wonder on 22 Feb 2017
FDA’s Pazdur and Blumenthal: the march of checkpoint inhibitors will continue
21 February 2017 - More approvals of new immune-checkpoint inhibitors, targeted and personalised therapies, as well as the use of ...
Posted by Michael Wonder on 14 Feb 2017
FDA drug trials snapshots and diversity when testing new drugs
13 February 2017 - Did you know that some drugs affect men and women differently? ...
Posted by Michael Wonder on 13 Feb 2017
The challenges of generating evidence to support precision medicine
13 February 2017 - Major recent advances in science and technology now enable new kinds of measurements that can characterise an ...
Posted by Michael Wonder on 09 Feb 2017
Promoting high-quality clinical research in children through strengthened international collaboration
9 February 2017 - Enpr-EMA workshop on 16 May 2017 opens for registration. ...
Posted by Michael Wonder on 08 Feb 2017
AusBiotech to initiate clinical trials advisory group
7 February 2017 - AusBiotech is inviting members to express interest in joining a new advisory group to provide guidance ...
Posted by Michael Wonder on 06 Feb 2017
Greg Hunt's innovation fund sent back to drawing board
5 February 2017 - Former industry minister Greg Hunt's $500 million national innovation fund has been sent back to the ...
Posted by Michael Wonder on 06 Feb 2017
Advanced therapy medicines: towards increased development and patient access
6 February 2017 - Follow-up activities addressing stakeholder needs. ...
Posted by Michael Wonder on 03 Feb 2017
U.S. House panel to take up bill to spur generic drug development
2 February 2017 - A U.S. House of Representatives subcommittee will take up bipartisan legislation next week to foster generic ...
Posted by Michael Wonder on 02 Feb 2017
Outcomes of early health technology assessment dialogues in medicinal product development
2 February 2017 - The development of medicinal products has been shifting towards a value-driven model. ...
Posted by Michael Wonder on 02 Feb 2017
Drug development challenges for small biopharmaceutical companies
1 February 2017 - Small biopharmaceutical companies are becoming increasingly important as drivers of innovation in drug development. ...